NCT01460641View on ClinicalTrials.gov

Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2018

Conditions
Rectal Cancer
Trial Locations (1)

94305

Stanford University, School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT01460641 - Perfusion CT as a Predictor of Treatment Response in Patients With Rectal Cancer | Biotech Hunter | Biotech Hunter